New oral anticoagulants in patients with atrial fibrillation - Authors'reply

Affiliations

¹ Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. Electronic address: cruff@partners.org.
² Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.

Comment

Christian T Ruff et al. Lancet. 2014.

. 2014 Jul 5;384(9937):25-6.

doi: 10.1016/S0140-6736(14)61106-5.

¹ Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. Electronic address: cruff@partners.org.
² Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.

No abstract available

Comment on

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials.
Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, Camm AJ, Weitz JI, Lewis BS, Parkhomenko A, Yamashita T, Antman EM. Ruff CT, et al. Lancet. 2014 Mar 15;383(9921):955-62. doi: 10.1016/S0140-6736(13)62343-0. Epub 2013 Dec 4. Lancet. 2014. PMID: 24315724
New oral anticoagulants in patients with atrial fibrillation.
Stöllberger C, Finsterer J. Stöllberger C, et al. Lancet. 2014 Jul 5;384(9937):23. doi: 10.1016/S0140-6736(14)61102-8. Lancet. 2014. PMID: 24998805 No abstract available.
New oral anticoagulants in patients with atrial fibrillation.
Shah R, Jamy O, Matin K. Shah R, et al. Lancet. 2014 Jul 5;384(9937):23-4. doi: 10.1016/S0140-6736(14)61103-X. Lancet. 2014. PMID: 24998806 No abstract available.
New oral anticoagulants in patients with atrial fibrillation.
Desborough MJ, Jairath V. Desborough MJ, et al. Lancet. 2014 Jul 5;384(9937):24. doi: 10.1016/S0140-6736(14)61105-3. Lancet. 2014. PMID: 24998807 No abstract available.
New oral anticoagulants in patients with atrial fibrillation.
Opstelten W, van den Donk M, Kuijpers T, Burgers JS. Opstelten W, et al. Lancet. 2014 Jul 5;384(9937):24. doi: 10.1016/S0140-6736(14)61104-1. Lancet. 2014. PMID: 24998808 No abstract available.